Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT01781793
Eligibility Criteria:
Inclusion Criteria - Fibrotic ILD participants:
* A multidisciplinary diagnosis of idiopathic pulmonary fibrosis (IPF), idiopathic fibrotic non-specific interstitial pneumonia (NSIP), chronic hypersensitivity pneumonitis (HP), or unclassifiable interstitial lung disease (ILD) with a differential diagnosis that consists of the above diagnoses
* Fibrosis on high resolution computed tomography (HRCT): honeycombing, reticulation, or traction bronchiectasis
* Oxygen saturation ≥ 92% by pulse oximetry at rest while breathing room air
Exclusion Criteria - Fibrotic ILD Participants:
* Concurrent participation in or recent completion (less than 6 weeks) of pulmonary rehabilitation
* A significant lung disease other than fibrotic ILD that, based on clinical assessment, could impair your ability to exercise
* Significant emphysema
* Pulmonary hypertension (high blood pressure in your lungs' arteries)
* Prednisone (a corticosteroid medication) in excess of 10mg/day for at least two weeks within three months of the first study visit
* An ulcer or tumor in your esophagus, or a nasal septum deviation
* Had recent nasopharyngeal surgery
* A cardiac pacemaker
* Allergies to latex and sensitivities to local anaesthetics
* Current smokers or smoked more than 20 packs per year in the past
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT01781793
Study Brief:
Protocol Section:
NCT01781793